Industry Briefs

Transferring East Bloc Technology Forget research universities. Forget national labs: This technology broker combs the scientific halls of the Soviet Union—the entire Eastern bloc—looking for new technologies that could be of value to U.S. companies. Kiser Research, started in 1980 by businessman John Kiser Ill and engineer Barney O’Meara, is currently working to find homes in the U.S. for advanced materials developed in the USSR and its neighboring nations. The company tra

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Forget research universities. Forget national labs: This technology broker combs the scientific halls of the Soviet Union—the entire Eastern bloc—looking for new technologies that could be of value to U.S. companies. Kiser Research, started in 1980 by businessman John Kiser Ill and engineer Barney O’Meara, is currently working to find homes in the U.S. for advanced materials developed in the USSR and its neighboring nations.

The company traces its beginnings back to two reports Kiser wrote for the State Department on technologies that had been transferred from the Soviet Union to the U.S. Although the USSR and its neighbors had created several significant inventions—soft contact lenses, for instance, come from Czechoslovakia and the metal staples used in surgery from the Soviet Union—no one had systematically examined these exports before Kiser.

Kiser Research has helped bring the West’s attention to a wide variety of discoveries in fields ranging from pharmaceuticals to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies